Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|September 14, 2024
CAIP-Induced ROS Production Contributes to Sustaining Atherosclerotic Process Associated with Helicobacter cinaedi Infection through Macrophages and Endothelial Cells ActivationErika Paolini, Stefano Cozzi, Gaia Codolo
International Journal of Molecular Sciences|February 11, 2023
The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASHErika Paolini, Miriam Longo, Alberto Corsini, et al.
International Journal of Molecular Sciences|November 13, 2025
Hepatic Zonation in MASLD: Old Question, New Challenge in the Era of Spatial OmicsErika Paolini, Miriam Longo, Marica Meroni, et al.
Biomedicines|March 25, 2022
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the SolutionMiriam Longo, Erika Paolini, Marica Meroni, et al.
International Journal of Molecular Sciences|April 30, 2021
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCCMiriam Longo, Erika Paolini, Marica Meroni, et al.
Journal of Advanced Research|February 18, 2024
A narrative review about cognitive impairment in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approachMarica Meroni, Miriam Longo, Erika Paolini, et al.
Metabolism: Clinical and Experimental|January 14, 2021
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?Miriam Longo, Marica Meroni, Erika Paolini, et al.
European Journal of Clinical Investigation|February 14, 2021
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approachesPaola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
International Journal of Molecular Sciences|August 29, 2024
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined ApplicationMiriam Longo, Erika Paolini, Pietro Di Benedetto, et al.
International Journal of Molecular Sciences|February 13, 2026
The I148M PNPLA3 Variant Forces Progressive Portal MASLD by Spatially Perturbing Metabolic Pathways Across Liver ZonesErika Paolini, Marica Meroni, Miriam Longo, et al.
Pageof 3